Maravai Lifesciences Holdings (MRVI) Revenue Growth (3y) (2023 - 2026)
Maravai Lifesciences Holdings (MRVI) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 981.05 Mn | 815.13 Mn | 33.70 Mn | -5.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.90% |
| Dec 31, 2025 | -37.55% |
| Sep 30, 2025 | -39.85% |
| Jun 30, 2025 | -41.98% |
| Mar 31, 2025 | -42.33% |
| Dec 31, 2024 | -37.21% |
| Sep 30, 2024 | -30.41% |
| Jun 30, 2024 | -31.69% |
| Mar 31, 2024 | -24.35% |
| Dec 31, 2023 | -8.99% |
| Sep 30, 2023 | -8.70% |
| Jun 30, 2023 | 13.68% |
| Mar 31, 2023 | 15.73% |